Insider · CIK 0001298669

Adams Timothy M

Reports to the SEC for 9 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001298669

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	SSTKShutterstock, Inc. · Restricted Stock UnitA Award	Director	AAward	+23.1K sh	—	—	23,107
2025-11-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−9,225 sh	$14.03	−$129K	186,863
2025-08-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−9,225 sh	$21.27	−$196K	196,088
2025-05-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−8,403 sh	$23.55	−$198K	205,313
2025-02-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−6,240 sh	$35.55	−$222K	213,716
2025-02-15	RPDRapid7, Inc.A Award	Chief Financial Officer	AAward	+17.8K sh	—	—	219,956
2025-02-14	RPDRapid7, Inc.A Award	Chief Financial Officer	AAward	+51.7K sh	—	—	202,111
2024-11-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−7,137 sh	$39.98	−$285K	150,377
2024-08-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−7,137 sh	$37.83	−$270K	157,514
2024-06-27	MODEL N, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−23.6K sh	$30.00	−$709K	0
2024-06-05	MODEL N, INC.G Gift	Director	GGift	−3,684 sh	—	—	23,627
2024-05-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−6,717 sh	$39.38	−$265K	164,651
2024-02-29	RPDRapid7, Inc.S Sale	Chief Financial Officer	SSale	−300 sh	$59.01	−$17.7K	170,739
2024-02-29	RPDRapid7, Inc.S Sale	Chief Financial Officer	SSale	−14.7K sh	$58.55	−$861K	171,039
2024-02-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,586 sh	$60.32	−$277K	185,739
2024-02-15	RPDRapid7, Inc.A Award	Chief Financial Officer	AAward	+35.7K sh	—	—	186,791
2024-02-15	MODEL N, INC.A Award	Director	AAward	+7,176 sh	—	—	27,311
2024-02-15	RPDRapid7, Inc.A Award	Chief Financial Officer	AAward	+3,534 sh	—	—	190,325
2023-11-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,228 sh	$52.09	−$272K	151,102
2023-08-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,228 sh	$48.89	−$256K	156,192
2023-05-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,228 sh	$46.70	−$244K	161,420
2023-02-16	MODEL N, INC.A Award	Director	AAward	+4,683 sh	—	—	20,135
2023-02-15	RPDRapid7, Inc.A Award	Chief Financial Officer	AAward	+65.3K sh	—	—	174,630
2023-02-15	RPDRapid7, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−8,378 sh	$50.38	−$422K	166,252
2022-12-05	MODEL N, INC.G Gift	Director	GGift	−1,004 sh	—	—	15,452
2022-12-05	RPDRapid7, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,500 sh	$30.00	+$75K	109,294
2022-11-25	MODEL N, INC.S Sale	Director	SSale	−6,913 sh	$38.27	−$265K	16,456
2022-11-25	MODEL N, INC.S Sale	Director	SSale	−3,685 sh	$38.75	−$143K	23,369
2022-11-14	MODEL N, INC.G Gift	Director	GGift	+1,000 sh	—	—	1,000
2022-11-14	MODEL N, INC.G Gift	Director	GGift	−1,000 sh	—	—	27,054
2022-11-11	MODEL N, INC.S Sale	Director	SSale	−11.8K sh	$39.77	−$469K	28,054
2022-05-09	RPDRapid7, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$65.50	+$328K	106,540
2022-02-18	MODEL N, INC.A Award	Director	AAward	+7,006 sh	—	—	39,848
2022-01-03	RPDRapid7, Inc.A Award	Chief Financial Officer	AAward	+102K sh	—	—	101,540
2021-02-19	MODEL N, INC.A Award	Director	AAward	+4,305 sh	—	—	32,842
2021-02-09	MODEL N, INC.S Sale	Director	SSale	−3,489 sh	$40.06	−$140K	28,537
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.4K sh	—	—	0
2021-01-12	MODEL N, INC.S Sale	Director	SSale	−8,119 sh	$39.46	−$320K	32,026
2020-09-15	MODEL N, INC.G Gift	Director	GGift	−625 sh	—	—	40,145
2020-09-14	MODEL N, INC.S Sale	Director	SSale	−2,315 sh	$36.00	−$83.3K	43,085
2020-09-14	MODEL N, INC.S Sale	Director	SSale	−2,315 sh	$36.10	−$83.6K	40,770
2020-06-17	Prevail Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2020-05-16	MODEL N, INC.A Award	Director	AAward	+124 sh	—	—	45,400
2020-02-14	MODEL N, INC.A Award	Director	AAward	+4,870 sh	—	—	45,455
2019-02-15	MODEL N, INC.A Award	Director	AAward	+14K sh	—	—	40,585
2018-02-16	MODEL N, INC.A Award	Director	AAward	+9,260 sh	—	—	26,628
2017-11-03	MODEL N, INC.A Award	Director	AAward	+280 sh	—	—	17,368
2017-02-17	MODEL N, INC.A Award	Director	AAward	+14.7K sh	—	—	17,088
2016-12-23	MODEL N, INC.A Award	Director	AAward	+2,349 sh	—	—	2,349

Recent filings

Accepted (ET)
Sep 104
Adams Timothy M0001298669-26-000004
SEC(opens sec.gov)
Nov 174
Adams Timothy M0001298669-25-000004
SEC(opens sec.gov)
Aug 194
Adams Timothy M0001628280-25-040808
SEC(opens sec.gov)
May 194
Adams Timothy M0001628280-25-026519
SEC(opens sec.gov)
Feb 194
Adams Timothy M0001560327-25-000012
SEC(opens sec.gov)
Nov 194
Adams Timothy M0001560327-24-000112
SEC(opens sec.gov)
Aug 194
Adams Timothy M0001560327-24-000097
SEC(opens sec.gov)
Jun 274
Adams Timothy M0001118417-24-000160
SEC(opens sec.gov)
Jun 74
Adams Timothy M0001118417-24-000141
SEC(opens sec.gov)
May 174
Adams Timothy M0001560327-24-000057
SEC(opens sec.gov)
Mar 44
Adams Timothy M0001560327-24-000025
SEC(opens sec.gov)
Feb 204
Adams Timothy M0001560327-24-000013
SEC(opens sec.gov)
Feb 164
Adams Timothy M0001118417-24-000043
SEC(opens sec.gov)
Nov 174
Adams Timothy M0001560327-23-000081
SEC(opens sec.gov)
Aug 174
Adams Timothy M0001560327-23-000068
SEC(opens sec.gov)

Companies

Address

C/O SHUTTERSTOCK, INC. 350 FIFTH AVENUE, 20TH FLOOR

NEW YORK, NY, 10118